These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34614093)

  • 21. Early diagnostic value of C-reactive protein as an inflammatory marker for moderate-to-severe bronchopulmonary dysplasia in premature infants with birth weight less than 1500 g.
    Yang Y; Li J; Mao J
    Int Immunopharmacol; 2022 Feb; 103():108462. PubMed ID: 34952464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk Calculator for Bronchopulmonary Dysplasia in Preterm Neonates: A Prospective Observational Study.
    Goyal M; Mascarenhas D; Nanavati R
    Indian J Pediatr; 2024 Aug; 91(8):781-787. PubMed ID: 37789210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Incidence and risk factors of bronchopulmonary dysplasia in premature infants in 10 hospitals in China].
    Collaborative Study Group for Bronchopulmonary Dysplasia of Prematurity in China
    Zhonghua Er Ke Za Zhi; 2011 Sep; 49(9):655-62. PubMed ID: 22176899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchopulmonary dysplasia in very and extremely low birth weight infants - analysis of selected risk factors.
    Kiciński P; Kęsiak M; Nowiczewski M; Gulczyńska E
    Pol Merkur Lekarski; 2017 Feb; 42(248):71-75. PubMed ID: 28258680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
    Ehrenkranz RA; Walsh MC; Vohr BR; Jobe AH; Wright LL; Fanaroff AA; Wrage LA; Poole K;
    Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes of serum interleukin-33 in preterm infants with bronchopulmonary dysplasia].
    Chen JL; Zhang CL
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jul; 22(7):716-720. PubMed ID: 32669167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants.
    Chen X; Li H; Qiu X; Yang C; Walther FJ
    BMC Pediatr; 2019 Apr; 19(1):138. PubMed ID: 31039810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment.
    Yoo H; Lee JA; Oh S; Jung YH; Sohn JA; Shin SH; Choi CW; Kim EK; Kim HS; Kim BI
    J Korean Med Sci; 2017 Jan; 32(1):115-123. PubMed ID: 27914140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Addition of SNAP to perinatal risk factors improves the prediction of bronchopulmonary dysplasia or death in critically ill preterm infants.
    Li Y; Yan J; Li M; Xiao Z; Zhu X; Pan J; Li X; Feng X
    BMC Pediatr; 2013 Sep; 13():138. PubMed ID: 24020335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased incidence of bronchopulmonary dysplasia in preterm infants exposed to preeclampsia.
    Ozkan H; Cetinkaya M; Koksal N
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2681-5. PubMed ID: 22759075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contributions of the NICHD neonatal research network to the diagnosis, prevention, and treatment of bronchopulmonary dysplasia.
    Jensen EA; Laughon MM; DeMauro SB; Cotten CM; Do B; Carlo WA; Watterberg KL
    Semin Perinatol; 2022 Nov; 46(7):151638. PubMed ID: 36085059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-terminal-probrain natriuretic peptide as a biomarker of moderate to severe bronchopulmonary dysplasia in preterm infants: A prospective observational study.
    Rodríguez-Blanco S; Oulego-Erroz I; Alonso-Quintela P; Terroba-Seara S; Jiménez-González A; Palau-Benavides M
    Pediatr Pulmonol; 2018 Aug; 53(8):1073-1081. PubMed ID: 29790673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small for gestational age birth may increase airflow limitation in bronchopulmonary dysplasia.
    Kim YH; Kim KW; Eun HS; Shin JE; Sol IS; Kim SY; Kim YS; Sohn MH; Namgung R
    Pediatr Pulmonol; 2020 Feb; 55(2):346-353. PubMed ID: 31794162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NTproBNP is a useful early biomarker of bronchopulmonary dysplasia in very low birth weight infants.
    Méndez-Abad P; Zafra-Rodríguez P; Lubián-López S; Benavente-Fernández I
    Eur J Pediatr; 2019 May; 178(5):755-761. PubMed ID: 30820654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors that affect the degree of bronchopulmonary dysplasia: Comparison by severity in the same gestational age.
    Kim SH; Han YS; Chun J; Lee MH; Sung TJ
    PLoS One; 2020; 15(7):e0235901. PubMed ID: 32673340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Impact of Atrial Left-to-Right Shunt on Pulmonary Hypertension in Preterm Infants with Moderate or Severe Bronchopulmonary Dysplasia.
    Choi EK; Jung YH; Kim HS; Shin SH; Choi CW; Kim EK; Kim BI; Choi JH
    Pediatr Neonatol; 2015 Oct; 56(5):317-23. PubMed ID: 26328892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between clinical severity of "new" bronchopulmonary dysplasia and HRCT abnormalities in VLBW infants.
    Sung TJ; Hwang SM; Kim MY; Park SG; Choi KY
    Pediatr Pulmonol; 2018 Oct; 53(10):1391-1398. PubMed ID: 29979483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying Risk Factors Shared by Bronchopulmonary Dysplasia, Severe Retinopathy, and Cystic Periventricular Leukomalacia in Very Preterm Infants for Targeted Intervention.
    Wang LW; Lin YC; Wang ST; Huang CC;
    Neonatology; 2018; 114(1):17-24. PubMed ID: 29621770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical significance of Ureaplasma urealyticum in bronchopulmonary dysplasia of prematurity].
    Bao Y; Zhao ZY; Shi LP; Ma XL; Chen Z; Luo F
    Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):767-70. PubMed ID: 23302568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.